Michelle Sholzberg

MDCM, MSc, FRCPC

Scientist, Keenan Research Centre for Biomedical Science (KRCBS)

Biography

Dr. Michelle Sholzberg received her MDCM and residency training in Internal Medicine at McGill University, completed additional postgraduate training in Hematology at the University of Toronto and a research hemostasis fellowship in Toronto and internationally. Dr. Sholzberg has a Master of Science from the University of Toronto in Clinical Epidemiology and Health Care Research and was awarded the Claire Bombardier award for career promise as a scientist. She is a clinician-scientist with a focus on coagulation, the Division Head of Hematology-Oncology and the Medical Director of the Coagulation Laboratory at St. Michael’s Hospital. She is also the Director of the Hematology-Oncology Clinical Research Group and Co-director of the Hematology-Immunology Translational Research Theme of the Li Ka Shing Knowledge Institute. Currently, she is involved in the study of: prediction tools for perioperative and traumatic bleeding, the intersection of women’s health and bleeding disorders, treatments for iron deficiency anemia, new treatments for immune thrombocytopenia and the management of COVID-19 coagulopathy.

Recent Publications

  1. Cooper, N, Jansen, AJG, Bird, R, Mayer, J, Sholzberg, M, Tarantino, MD et al.. Efficacy and Safety Results With Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Patients With Immune Thrombocytopenia: Phase 2 Part B Study. Am J Hematol. 2025;100 (3):439-449. doi: 10.1002/ajh.27539. PubMed PMID:39844469 PubMed Central PMC11803537.
  2. Ge, S, Ali, S, Haldane, V, Bekdache, C, Tang, GH, Sholzberg, M et al.. An approach to Hemequity: Identifying the barriers and facilitators of iron deficiency reduction strategies in low- to middle-income countries. Br J Haematol. 2025; :. doi: 10.1111/bjh.19984. PubMed PMID:39763078 .
  3. WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Vale, CL, Godolphin, PJ, Fisher, DJ, Higgins, JPT, McAleenan, A et al.. Anticoagulation Among Patients Hospitalized for COVID-19 : A Systematic Review and Prospective Meta-analysis. Ann Intern Med. 2025;178 (1):59-69. doi: 10.7326/ANNALS-24-00800. PubMed PMID:39715559 .
  4. Chaigneau, M, Bowman, M, Wilton, P, Card, R, Poon, MC, Lillicrap, D et al.. The history of women and hemophilia: a narrative review of evolving beliefs and testing practices. J Thromb Haemost. 2024; :. doi: 10.1016/j.jtha.2024.12.004. PubMed PMID:39675566 .
  5. Escobar, M, Lassila, R, Bekdache, C, Owaidah, T, Sholzberg, M. Use of antithrombotic therapy in patients with hemophilia: a selected synopsis of the European Hematology Association - International Society on Thrombosis and Haemostasis - European Association for Hemophilia and Allied Disorders - European Stroke Organization Clinical Practice Guidance document. J Thromb Haemost. 2025;23 (2):745-749. doi: 10.1016/j.jtha.2024.10.033. PubMed PMID:39571935 .
  6. Harel, Z, Smyth, B, Badve, SV, Blum, D, Beaubien-Souligny, W, Silver, SA et al.. Anticoagulation for Patients with Atrial Fibrillation Receiving Dialysis: A Pilot Randomized Controlled Trial. J Am Soc Nephrol. 2024; :. doi: 10.1681/ASN.0000000000000495. PubMed PMID:39495569 .
  7. Skeith, L, James, P, Kouides, P, Uminski, K, Duffett, L, Jackson, S et al.. Pregnancy loss in individuals with von Willebrand disease and unspecified mucocutaneous bleeding disorders: a multicenter cohort study. J Thromb Haemost. 2025;23 (2):429-439. doi: 10.1016/j.jtha.2024.09.037. PubMed PMID:39454883 .
  8. Stephen, M, Elbaz, C, Hanif, H, Pavenski, K, Teitel, J, Sholzberg, M et al.. Cross-reacting antiporcine factor VIII inhibitors in patients with acquired hemophilia A. Res Pract Thromb Haemost. 2024;8 (6):102553. doi: 10.1016/j.rpth.2024.102553. PubMed PMID:39309227 PubMed Central PMC11416523.
  9. Ward, C, Curry, N, El-Ekiaby, M, Jurk, K, Versteeg, HH, Keragala, C et al.. Erratum to 'Illustrated State-of-the-Art Capsules of the ISTH 2024 Congress' [Research and Practice in Thrombosis and Haemostasis Volume 8, Issue 4, May 2024, 102432]. Res Pract Thromb Haemost. 2024;8 (5):102498. doi: 10.1016/j.rpth.2024.102498. PubMed PMID:39268352 PubMed Central PMC11391028.
  10. Cogan, JC, Meyer, J, Jiang, Z, Sholzberg, M. Iron deficiency resolution and time to resolution in an American health system. Blood Adv. 2024;8 (23):6029-6034. doi: 10.1182/bloodadvances.2024013197. PubMed PMID:39145727 PubMed Central PMC11635663.
Search PubMed

Affiliations & Other Activities

  • Staff Physician, Division of Hematology, St. Michael’s Hospital
  • Assistant Professor, Department of Medicine, University of Toronto